O Conselho Brasileiro de Oftalmologia é a maior entidade representativa dos Oftalmologistas brasileiros.
Nesse canal, você encontra entrevistas com especialistas, estudo de caso, notícias sobre Oftalmologia e saúde como todo e muito mais!
CBO OFTALMOLOGIA
Claim This Podcastby Podcast CBO Oftalmologia
5.0(3 reviews)
78 episodes
Updated Bi-weekly
Accepts GuestsHas SponsorsLocation 🇧🇷
Podcast Overview
O Conselho Brasileiro de Oftalmologia é a maior entidade representativa dos Oftalmologistas brasileiros. Nesse canal, você encontra entrevistas com especialistas, estudo de caso, notícias sobre Oftalmologia e saúde como todo e muito mais!
Language
🇵🇹
Publishing Since
11/11/2020
1 verified contact email on file for CBO OFTALMOLOGIA
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
July 27, 2026
Entrevista Saúde Ocular - Senador Astronauta Marcos Pontes
<p>Entrevistado: Marcos Pontes - Astronauta e SenadorApresentador: Maria Auxiliadora Frazão - Presidente CBO</p>
July 24, 2026
Glaucoma: a doença que rouba a visão sem avisar | Podacst 24 Dias Pelo Glaucoma
<p>O glaucoma é uma doença silenciosa e uma das principais causas de cegueira irreversível no mundo. Por isso, informação e diagnóstico precoce fazem toda a diferença.</p><p>Neste episódio especial do <strong>Podcast CBO</strong>, a ex-presidente do CBO, <strong>Dra. Wilma Lelis</strong>, e o presidente da Sociedade Brasileira de Glaucoma (SBG), <strong>Dr. Roberto Vessani</strong>, recebem o influenciador digital <strong>Peter Jordan</strong>, que compartilha sua experiência com a doença e reforça a importância da conscientização e do acompanhamento oftalmológico.</p><p>🎧 O episódio faz parte da série de podcasts da campanha <strong>24h pelo Glaucoma</strong></p><p></p>
July 15, 2026
Glaucoma e Autonomia Médica - AMB
<p>Entrevista: Florisval Meinão - Secretário Geral AMBCoordenação: Maria Auxiliadora Frazão - Presidente CBO</p>
78 total episodes available
Similar Podcasts
Discover related shows you might enjoy
Deep-dive analytics for CBO OFTALMOLOGIA
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is CBO OFTALMOLOGIA?
- How often does this podcast release new episodes?
This podcast updates bi-weekly.
- Where can I listen to this podcast?
This podcast is available on 8 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
No, this podcast does not typically feature guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.